Glenmark gets CDSCO panel nod to manufacture and market COPD drug Dr. Divya Colin9 May 2022 6:52 PM ISTNew Delhi: Based on the justification provided by the pharmaceutical major Glenmark pharmaceuticals, the Subject Expert Committee (SEC) of the Central...
CDSCO allows import of drugs with residual shelf life less than 60 percent till October 31, 2021 Susmita Roy8 May 2022 12:00 PM ISTNew Delhi: With an aim to ensure drug availability in sufficient quantity in the domestic market, the apex drug regulator, Central Drugs Standard...
CDSCO panel directs GSK to generate safety, immunogenicity data on Indian population for INFANRIX-IPV Dr. Divya Colin6 May 2022 7:06 PM ISTNew Delhi: Rejecting pharmaceuticals major GSK's proposal to import INFANRIX-IPV in the country without conducting a local clinical trial, the Subject...
CDSCO panel directs SII to submit safety and immunogenicity data for TB vaccine Susmita Roy5 May 2022 7:10 PM ISTNew Delhi: Rejecting the vaccine major Serum Inst. of India's proposal for emergency use authorization of rBCG vaccine for prevention of Tuberculosis...
CDSCO panel gives Emcure Pharma waiver on Phase IV CT for Lamivudine plus Dolutegravir Dr. Divya Colin27 April 2022 6:19 PM ISTNew Delhi: Pharmaceutical major, Emcure Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under Central Drug...
Gufic Biosciences bags CDSCO approval to manufacture drug for severe fungal infections Ruchika Sharma27 April 2022 12:52 PM ISTIsavuconazole for Injection 200 mg/vial is indicated for the treatment of patients who are 18 years of age and above.
Dr. Reddy's gets CDSCO panel nod to study Fosravuconazole L Lysine Ethanolate Capsule Dr. Divya Colin25 April 2022 8:06 PM ISTNew Delhi: Granting the waiver of bioequivalence study, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO)...
Novo Nordisk bags CDSCO panel nod to study anti neoplastic drug Concizumab Dr. Divya Colin24 April 2022 12:30 PM ISTNew Delhi: In line with the drug major Novo-Nordisk's proposal for Phase IIIa clinical trial of antineoplastic drug Concizumab, the Subject Expert...
Setback: AstraZeneca proposal to market, manufacture Olaparib rejected by CDSCO panel Dr. Divya Colin23 April 2022 5:03 PM ISTNew Delhi: In a major setback to AstraZeneca, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has...
Biological E gets CDSCO panel nod for Corbevax EUA for 5-11 years old Ruchika Sharma22 April 2022 1:10 PM ISTBiological E's Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years.
CoSara Diagnostics gets CDSCO clearance for Hepatitis C Viral Load Test Ruchika Sharma22 April 2022 11:00 AM ISTSalt Lake City: Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular...
Sun Pharma gets CDSCO committee approval for manufacturing Ranibizumab Susmita Roy16 April 2022 3:22 PM ISTNew Delhi: In a significant development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO)...
